Scarinci Hollenbeck, LLC, LLCScarinci Hollenbeck, LLC, LLC

COVID-19 Alerts

Top Considerations for Boards of Directors Addressing COVID-19

Author: Dan Brecher

Date: May 20, 2020

Key Contacts

Back

Boards of directors play a pivotal role in helping businesses navigate the challenges created by the ongoing coronavirus (COVID-19) pandemic…

Boards of directors play a pivotal role in helping businesses navigate the challenges created by the ongoing coronavirus (COVID-19) pandemic. While many things have changed over the past few months, the fiduciary duties of care and loyalty to the company remain unchanged and may even be more important during these unprecedented times.

Fiduciary Duties Owed by Boards of Directors

Directors have certain fiduciary duties to the company and, thus, to its shareholders. Under the corporate laws of most states, directors have two main fiduciary duties — the duty of care and the duty of loyalty.

Under the New Jersey Business Corporation Act (NJBCA), directors must “discharge their duties in good faith and with that degree of diligence, care and skill which ordinarily prudent people would exercise under similar circumstances in like positions.” Directors ordinarily satisfy this duty if, acting in good faith, they rely upon: an opinion of counsel for the corporation; written reports setting forth financial data concerning the corporation and prepared by an independent public accountant or certified public accountant or firm of such accountants; financial statements, books of account or reports of the corporation represented to them to be correct by the president, the officer of the corporation having charge of its books of account, or the person presiding at a meeting of the board; or written reports of committees of the board.

Directors are also bound by a duty of loyalty, which means that when their personal interests conflict with the interests of the corporation, they are legally bound to put the corporation’s interest above their own. The duty of loyalty typically involves contracts with the corporation and corporate opportunity. While officers and directors are not completely prohibited from contracting with their company, such transactions are closely scrutinized to verify that they are “fair to the corporation.” If they are not, the transaction must be approved by disinterested board members or shareholders that have been fully advised of the potential conflict of interest. The corporate opportunity doctrine mandates that whenever directors or officers learn of an opportunity that may be beneficial to the corporation, they are obligated to first present the opportunity to the corporation. The failure to disclose the corporate opportunity is considered a breach of the duty of loyalty.

COVID-19 Considerations for Boards

To fulfill their fiduciary duties, boards should become informed about how COVID-19 is impacting the company and how it may continue to impact it in the future. To keep pace with how quickly the situation is changing, boards may need to meet more frequently or to establish a special committee dedicated to COVID-19.

While there are many uncertainties about this pandemic, boards should play an active role in overseeing how management plans to respond to these challenges. Below are several important issues to consider:

  • Crisis Response/Communications: Boards should verify that the company has a crisis management plan in place and that it is working effectively. Providing clear and transparent messaging to employees and other stakeholders should also be a priority. Communications should emphasize the importance of protecting health and safety as the company responds to the COVID-19 crisis. 
  • Business Continuity Plans: Given the uncertainty associated with COVID-19, including the risk of additional rounds of business restrictions, it is imperative to verify that the company has comprehensive continuity and contingency plans in place to mitigate the risks posed by business closures, workforce unavailability, and supply chain disruptions. Boards should also evaluate the adequacy of succession plans for directors and senior management.
  • Cybersecurity Risks: Many companies quickly transitioned to a remote workforce, which significantly increased the risk of a data breach. Boards should evaluate how management is addressing these risks, such as those resulting from employee use of personal computers, accessing company information via home wi-fi connections, or storing confidential information outside the company’s servers. Boards and management should then evaluate their existing policies and procedures to determine what changes may be needed to address new cyber threats.
  • Financial Health: COVID-19 is forcing many businesses to reassess their short and long-term plans. Boards should work with management to reevaluate the company’s levels of liquidity, indebtedness, and allocation of capital. Other considerations involve whether the company should consider seeking additional financing, or amending the terms of existing debt arrangements. Companies may also want to consider the need to defer, suspend, or reduce dividends.
  • Compliance Obligations: Regulators have relaxed certain compliance obligations/deadlines in response to COVID-19. At the same time, the crisis has also triggered the need for additional disclosures in some circumstances. It is imperative that boards/management stay on top of their regulatory obligations and determine what changes may be necessary in response to the pandemic.
  • Government Relief: Boards and management should evaluate whether the company is eligible for any state or federal relief, such as the Coronavirus Aid, Relief, and Economic Security (CARES) Act. With additional stimulus packages and other regulatory relief likely in the future, it is important to stay on top of these developments.
  • Future Opportunities: Boards should also keep their eye towards the future. While the COVID-19 pandemic has caused significant economic upheaval, it has also created opportunities for certain businesses, such as lower-cost acquisitions. The outbreak has also resulted in certain operational, technological, and policy changes that may be worthwhile retaining after the crisis has passed.

The challenges posed by COVID-19 are wide-ranging, so boards and company management should leverage all available resources, including financial, operational, and legal advisors. At Scarinci Hollenbeck, our attorneys are here to help businesses of all sizes navigate the complex and ever-changing legal environment attendant to the COVID-19 crisis.

If you have questions, please contact us

If you have any questions or if you would like to discuss the matter further, please contact me, Dan Brecher, or the Scarinci Hollenbeck attorney with whom you work, at 201-896-4100.

No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.

Scarinci Hollenbeck, LLC, LLC

Related Posts

See all
How the Courts Are Reacting to COVID-19 Contract Cases post image

How the Courts Are Reacting to COVID-19 Contract Cases

Breach of contract cases arising out of the COVID-19 pandemic are slowly making their way through the court system… Breach of contract cases arising out of the coronavirus (COVID-19) pandemic are slowly making their way through the court system. The early decisions shed light on how courts are handling force majeure provisions and contract defenses […]

Author: Dan Brecher

Link to post with title - "How the Courts Are Reacting to COVID-19 Contract Cases"
What to Know About USPTO COVID-19 Prioritized Trademark Examination Program post image

What to Know About USPTO COVID-19 Prioritized Trademark Examination Program

The USPTO recently announced a new COVID-19 prioritized examination program for certain trademark and service mark applications… The U.S. Patent and Trademark Office (USPTO) recently announced a new COVID-19 prioritized examination program for certain trademark and service mark applications. It is available for products that are subject to U.S. Food and Drug Administration (FDA) approval […]

Author: David A. Einhorn

Link to post with title - "What to Know About USPTO COVID-19 Prioritized Trademark Examination Program"
Reopening Resources for NJ Restaurants post image

Reopening Resources for NJ Restaurants

After a difficult few months, New Jersey restaurants are gradually reopening their doors for on-premises dining. After a difficult few months, New Jersey restaurants are gradually reopening their doors for on-premises dining. For restaurant operators and their customers, it is important to understand what is required to reopen safely. This article outlines the guidance provided […]

Author: Michael Jimenez

Link to post with title - "Reopening Resources for NJ Restaurants"
Remote Regulatory Exam and Response Insights post image

Remote Regulatory Exam and Response Insights

The Regulatory Examination Process has evolved in positive directions over the past several years. Thanks to these prior process improvements, the SEC, CFTC/NFA and FINRA are able to conduct regulatory exams virtually… The Regulatory Examination Process has clearly evolved in positive directions over the past several years. Thanks in part to these prior process improvements, […]

Author: Scarinci Hollenbeck, LLC

Link to post with title - "Remote Regulatory Exam and Response Insights"
Understanding the Risks and Benefits of Remote Legal Proceedings post image

Understanding the Risks and Benefits of Remote Legal Proceedings

The coronavirus (COVID-19) pandemic has forced us to change the way we conduct everyday activities… The coronavirus (COVID-19) pandemic has forced us to change the way we conduct everyday activities. Court proceedings, arbitrations, and mediations are no exception, and parties to such proceedings increasingly rely on video conferencing to go “virtual.” While technology can allow […]

Author: Joel N. Kreizman

Link to post with title - "Understanding the Risks and Benefits of Remote Legal Proceedings"
Will COVID-19 Prompt an Uptick in White-Collar Crime Investigations? post image

Will COVID-19 Prompt an Uptick in White-Collar Crime Investigations?

While the COVID-19 pandemic may be slowing the pace at which white-collar crimes are prosecuted, it would be unwise to expect that the pace of white-collar investigations will slow… While the coronavirus (COVID-19) pandemic may be slowing the pace at which white-collar crimes are prosecuted, it would be unwise to expect that the pace of […]

Author: Gregg H. Hilzer

Link to post with title - "Will COVID-19 Prompt an Uptick in White-Collar Crime Investigations?"

No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.

Sign up to get the latest from our attorneys!

Explore What Matters Most to You.

Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.

Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.

Top Considerations for Boards of Directors Addressing COVID-19

Author: Dan Brecher

Boards of directors play a pivotal role in helping businesses navigate the challenges created by the ongoing coronavirus (COVID-19) pandemic…

Boards of directors play a pivotal role in helping businesses navigate the challenges created by the ongoing coronavirus (COVID-19) pandemic. While many things have changed over the past few months, the fiduciary duties of care and loyalty to the company remain unchanged and may even be more important during these unprecedented times.

Fiduciary Duties Owed by Boards of Directors

Directors have certain fiduciary duties to the company and, thus, to its shareholders. Under the corporate laws of most states, directors have two main fiduciary duties — the duty of care and the duty of loyalty.

Under the New Jersey Business Corporation Act (NJBCA), directors must “discharge their duties in good faith and with that degree of diligence, care and skill which ordinarily prudent people would exercise under similar circumstances in like positions.” Directors ordinarily satisfy this duty if, acting in good faith, they rely upon: an opinion of counsel for the corporation; written reports setting forth financial data concerning the corporation and prepared by an independent public accountant or certified public accountant or firm of such accountants; financial statements, books of account or reports of the corporation represented to them to be correct by the president, the officer of the corporation having charge of its books of account, or the person presiding at a meeting of the board; or written reports of committees of the board.

Directors are also bound by a duty of loyalty, which means that when their personal interests conflict with the interests of the corporation, they are legally bound to put the corporation’s interest above their own. The duty of loyalty typically involves contracts with the corporation and corporate opportunity. While officers and directors are not completely prohibited from contracting with their company, such transactions are closely scrutinized to verify that they are “fair to the corporation.” If they are not, the transaction must be approved by disinterested board members or shareholders that have been fully advised of the potential conflict of interest. The corporate opportunity doctrine mandates that whenever directors or officers learn of an opportunity that may be beneficial to the corporation, they are obligated to first present the opportunity to the corporation. The failure to disclose the corporate opportunity is considered a breach of the duty of loyalty.

COVID-19 Considerations for Boards

To fulfill their fiduciary duties, boards should become informed about how COVID-19 is impacting the company and how it may continue to impact it in the future. To keep pace with how quickly the situation is changing, boards may need to meet more frequently or to establish a special committee dedicated to COVID-19.

While there are many uncertainties about this pandemic, boards should play an active role in overseeing how management plans to respond to these challenges. Below are several important issues to consider:

  • Crisis Response/Communications: Boards should verify that the company has a crisis management plan in place and that it is working effectively. Providing clear and transparent messaging to employees and other stakeholders should also be a priority. Communications should emphasize the importance of protecting health and safety as the company responds to the COVID-19 crisis. 
  • Business Continuity Plans: Given the uncertainty associated with COVID-19, including the risk of additional rounds of business restrictions, it is imperative to verify that the company has comprehensive continuity and contingency plans in place to mitigate the risks posed by business closures, workforce unavailability, and supply chain disruptions. Boards should also evaluate the adequacy of succession plans for directors and senior management.
  • Cybersecurity Risks: Many companies quickly transitioned to a remote workforce, which significantly increased the risk of a data breach. Boards should evaluate how management is addressing these risks, such as those resulting from employee use of personal computers, accessing company information via home wi-fi connections, or storing confidential information outside the company’s servers. Boards and management should then evaluate their existing policies and procedures to determine what changes may be needed to address new cyber threats.
  • Financial Health: COVID-19 is forcing many businesses to reassess their short and long-term plans. Boards should work with management to reevaluate the company’s levels of liquidity, indebtedness, and allocation of capital. Other considerations involve whether the company should consider seeking additional financing, or amending the terms of existing debt arrangements. Companies may also want to consider the need to defer, suspend, or reduce dividends.
  • Compliance Obligations: Regulators have relaxed certain compliance obligations/deadlines in response to COVID-19. At the same time, the crisis has also triggered the need for additional disclosures in some circumstances. It is imperative that boards/management stay on top of their regulatory obligations and determine what changes may be necessary in response to the pandemic.
  • Government Relief: Boards and management should evaluate whether the company is eligible for any state or federal relief, such as the Coronavirus Aid, Relief, and Economic Security (CARES) Act. With additional stimulus packages and other regulatory relief likely in the future, it is important to stay on top of these developments.
  • Future Opportunities: Boards should also keep their eye towards the future. While the COVID-19 pandemic has caused significant economic upheaval, it has also created opportunities for certain businesses, such as lower-cost acquisitions. The outbreak has also resulted in certain operational, technological, and policy changes that may be worthwhile retaining after the crisis has passed.

The challenges posed by COVID-19 are wide-ranging, so boards and company management should leverage all available resources, including financial, operational, and legal advisors. At Scarinci Hollenbeck, our attorneys are here to help businesses of all sizes navigate the complex and ever-changing legal environment attendant to the COVID-19 crisis.

If you have questions, please contact us

If you have any questions or if you would like to discuss the matter further, please contact me, Dan Brecher, or the Scarinci Hollenbeck attorney with whom you work, at 201-896-4100.

Let`s get in touch!

* The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!

Please select a category(s) below: